Maki Mizuguchi

Shizuoka, 4118777, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Analysis of HLA class I allele genotypes and immune-related gene alterations in patients with pan-cancer using whole-exome and whole-genome sequencing.

Analysis of HLA class I allele genotypes and immune-related gene alterations in patients with pan-cancer using whole-exome and whole-genome sequencing.

Journal: Biomedical research (Tokyo, Japan)

Published: December 03, 2025

Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing.

Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing.

Journal: Scientific reports

Published: April 18, 2025

Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.

Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.

Journal: Scientific reports

Published: April 30, 2024

Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients.

Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients.

Journal: Biomedical research (Tokyo, Japan)

Published: August 21, 2022

Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.

Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.

Journal: Scientific reports

Published: August 01, 2022

Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study.

Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study.

Journal: Medicine

Published: May 26, 2021

Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study.

Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study.

Journal: Japanese journal of clinical oncology

Published: May 18, 2021

JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing.

JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing.

Journal: Human genome variation

Published: May 07, 2021

Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.

Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.

Journal: Human genetics

Published: November 11, 2019

Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.

Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.

Journal: Biomedical research (Tokyo, Japan)

Published: August 23, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026